Jennifer E. Glass, LGC

Genetic Testing in Patients with Neurodevelopmental Disorders: Experience of 511 Patients at Cincinnati Children's Hospital Medical Center. Du, X; Glass, JE; Balow, S; Dyer, LM; Rathbun, PA; Guan, Q; Liu, J; Wu, Y; Dawson, DB; Walters-Sen, L; Smolarek, TA; Zhang, W. Journal of Autism and Developmental Disorders. 2022; 52:4828-4842.

RHOA signaling defects result in impaired axon guidance in iPSC-derived neurons from patients with tuberous sclerosis complex. Catlett, TS; Onesto, MM; McCann, AJ; Rempel, SK; Glass, J; Franz, DN; Gómez, TM. Nature Communications. 2021; 12:2589.

Trisomy 9 mosaic syndrome: Sixteen additional patients with new and/or less commonly reported features, literature review, and suggested clinical guidelines. Li, M; Glass, J; Du, X; Dubbs, H; Harr, MH; Falk, M; Smolarek, T; Hopkin, RJ; Zackai, E; Sheppard, SE. American Journal of Medical Genetics, Part A. 2021; 185:2374-2383.

Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex. Tian, X; Glass, JE; Kwiatkowski, DJ; Towbin, AJ; Li, Y; Sund, KL; Krueger, DA; Franz, DN; McCormack, FX; Gupta, N. Annals of the American Thoracic Society. 2021; 18:815-819.